172 related articles for article (PubMed ID: 36069781)
21. The dawn of a new synthetic opioid era: the need for innovative interventions.
Pardo B; Taylor J; Caulkins J; Reuter P; Kilmer B
Addiction; 2021 Jun; 116(6):1304-1312. PubMed ID: 32869394
[TBL] [Abstract][Full Text] [Related]
22. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
[TBL] [Abstract][Full Text] [Related]
23. Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use.
Stein MD; Kenney SR; Anderson BJ; Bailey GL
J Subst Abuse Treat; 2019 Sep; 104():144-147. PubMed ID: 31370978
[TBL] [Abstract][Full Text] [Related]
24. Designing traceable opioid material
Mojica MA; Carter MD; Isenberg SL; Pirkle JL; Hamelin EI; Shaner RL; Seymour C; Sheppard CI; Baldwin GT; Johnson RC
Toxicol Lett; 2019 Dec; 317():53-58. PubMed ID: 31560942
[TBL] [Abstract][Full Text] [Related]
25. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
[TBL] [Abstract][Full Text] [Related]
26. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
[No Abstract] [Full Text] [Related]
27. Reversal of overdose on fentanyl being illicitly sold as heroin with naloxone nasal spray: A case report.
Fareed A; Buchanan-Cummings AM; Crampton K; Grant A; Drexler K
Am J Addict; 2015 Aug; 24(5):388-90. PubMed ID: 26039379
[TBL] [Abstract][Full Text] [Related]
28. On the front lines of the opioid epidemic: Rescue by naloxone.
Skolnick P
Eur J Pharmacol; 2018 Sep; 835():147-153. PubMed ID: 30092179
[TBL] [Abstract][Full Text] [Related]
29. Treatment of opioid overdose: current approaches and recent advances.
Britch SC; Walsh SL
Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972
[TBL] [Abstract][Full Text] [Related]
30. Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review.
Moe J; Godwin J; Purssell R; O'Sullivan F; Hau JP; Purssell E; Curran J; Doyle-Waters MM; Brasher PMA; Buxton JA; Hohl CM
CJEM; 2020 Mar; 22(2):178-186. PubMed ID: 31955714
[TBL] [Abstract][Full Text] [Related]
31. Opioid overdose in the age of fentanyl: Risk factor differences among subpopulations of overdose survivors.
Kline A; Mattern D; Cooperman N; Williams JM; Dooley-Budsock P; Foglia R; Borys S
Int J Drug Policy; 2021 Apr; 90():103051. PubMed ID: 33321284
[TBL] [Abstract][Full Text] [Related]
32. Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose.
Griswold MK; Chai PR; Krotulski AJ; Friscia M; Chapman B; Boyer EW; Logan BK; Babu KM
Clin Toxicol (Phila); 2018 Jan; 56(1):37-42. PubMed ID: 28681615
[TBL] [Abstract][Full Text] [Related]
33. Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market.
Duhart Clarke SE; Kral AH; Zibbell JE
Int J Drug Policy; 2022 Jan; 99():103467. PubMed ID: 34662847
[TBL] [Abstract][Full Text] [Related]
34. Investigating opioid preference to inform safe supply services: A cross sectional study.
Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and disparities in opioid overdose response training among people who inject drugs, San Francisco: Naloxone training among injectors in San Francisco.
Kim K; Oh H; Miller D; Veloso D; Lin J; McFarland W
Int J Drug Policy; 2021 Apr; 90():102778. PubMed ID: 32507683
[TBL] [Abstract][Full Text] [Related]
36. Using ADAPT-ITT to Modify a Telephone-Based HIV Prevention Intervention for SMS Delivery: Formative Study.
Davis T; DiClemente RJ; Prietula M
JMIR Form Res; 2020 Oct; 4(10):e22485. PubMed ID: 32831178
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids.
Roxburgh A; Hall WD; Gisev N; Degenhardt L
Drug Alcohol Depend; 2019 Dec; 205():107533. PubMed ID: 31704378
[TBL] [Abstract][Full Text] [Related]
38. Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine - 25 States, July-December 2017 to January-June 2018.
Gladden RM; O'Donnell J; Mattson CL; Seth P
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(34):737-744. PubMed ID: 31465320
[TBL] [Abstract][Full Text] [Related]
39. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
Kerensky T; Walley AY
Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
[TBL] [Abstract][Full Text] [Related]
40. Protocol for Take-home naloxone In Multicentre Emergency (TIME) settings: feasibility study.
Jones M; Bell F; Benger J; Black S; Buykx P; Dixon S; Driscoll T; Evans B; Edwards A; Fuller G; Goodacre S; Hoskins R; Hughes J; John A; Jones J; Moore C; Sampson F; Watkins A; Snooks H
Pilot Feasibility Stud; 2020; 6():96. PubMed ID: 32670598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
